Key result
Vein of Marshall ethanol infusion yields permanent scars comparable between voltage maps and LGE-CMR.
Why the study?
It was unknown how scar formation from ethanol infusion into the vein of Marshall impacts left atrial structure and function.
Does ethanol infusion into the vein of Marshall (EI-VOM) impact left atrial structure and function in patients undergoing atrial fibrillation ablation?
Observational (n=21)
Does ethanol infusion into the vein of Marshall (EI-VOM) impact left atrial structure and function in patients undergoing atrial fibrillation ablation?
p-value: p=0.287
Ethanol infusion into the vein of Marshall during atrial fibrillation ablation creates permanent scarring and reduces left atrial volume without adversely affecting left atrial functional parameters at 3 months.
Supports EI-VOM scar durability without LA dysfunction at 3 months; leaves open randomized confirmation of AF outcomes.
BACKGROUND: Ethanol infusion into the vein of Marshall (EI-VOM) is an adjunctive therapy to pulmonary vein isolation (PVI), which improves the efficacy of persistent atrial fibrillation (AF) ablation procedures. It is unknown how EI-VOM scar formation impacts left atrium (LA) structure and function. OBJECTIVE: To characterize scar formation after EI-VOM, and its impact on LA function, by cardiac magnetic resonance (CMR). METHODS: Consecutive patients referred for persistent AF ablation, or any repeat procedure, were included. Ablation strategy included PVI, EI-VOM and linear lesions when deemed necessary. LA was assessed by late gadolinium enhancement (LGE) CMR at baseline and 3-month follow-up. CMR was post-processed off-line with dedicated software. The LA was regionalized into 17 segments, and global and regional scarring were calculated. Strain parameters were analyzed-including LA reservoir, conduit, and booster strain; LA ejection fraction; and LA passive and active emptying function. Follow-up LGE-CMR reconstruction was coregistered with the voltage map, ablation RF points, and fluoroscopy to compare the scar location with the VOM trajectory. RESULTS: This study included 21 patients (65 ± 8 years; 76% men; 57% ablation of persistent AF). After EI-VOM, 95% of patients presented new low-voltage areas, all of whom exhibited new LGE-CMR scarring at follow-up. Voltage map and LGE-CMR coregistration showed comparable scar areas (p = 0.287). LGE-CMR scarring frequently involved the whole VOM trajectory, predominantly affecting the LA ridge, mitral isthmus, and left posterior wall. LA volume was significantly reduced after ablation, without significant changes in LA functional parameters. CONCLUSION: EI-VOM causes permanent scarring at 3-month follow-up, with no adverse impact on CMR LA functional parameters.
No takes yet. Share an insight, caveat, or question.
Aranyó et al. (2024) conducted an observational in Persistent atrial fibrillation (n=21). Ethanol infusion into the vein of Marshall (EI-VOM) was evaluated on Scar area comparison between voltage map and LGE-CMR coregistration (p=0.287). Ethanol infusion into the vein of Marshall caused permanent scarring at 3 months with comparable scar areas between voltage maps and LGE-CMR (p=0.287) and no adverse impact on LA function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: